Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Debt to Capital Ratio of 1.06 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$724.51M |
|
$22.42M |
|
$438.25M |
|
$286.25M |
|
$613.14M |
|
$111.37M |
|
$-59.66M |
|
$51.71M |
|
$51.71M |
|
$35.61M |
|
$35.61M |
|
$35.61M |
|
$35.61M |
|
$111.37M |
|
$178.36M |
|
313.74M |
|
322.36M |
|
$0.07 |
|
$0.07 |
|
| Balance Sheet Financials | |
$1.58B |
|
$440.33M |
|
$1.84B |
|
$3.42B |
|
$1.11B |
|
$2.15B |
|
$2.43B |
|
$3.54B |
|
$-112.53M |
|
$-1.36B |
|
$-112.53M |
|
314.04M |
|
| Cash Flow Statement Financials | |
$91.23M |
|
$-44.34M |
|
$-80.85M |
|
$118.42M |
|
$83.67M |
|
$-34.75M |
|
$15.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.43 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
1.06 |
-21.93 |
|
39.51% |
|
15.37% |
|
15.37% |
|
-- |
|
7.14% |
|
3.09% |
|
$51.98M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.72 |
|
0.90 |
|
100.52 |
|
-31.64% |
|
-2.62% |
|
1.04% |
|
1.75% |
|
$-0.36 |
|
$0.16 |
|
$0.28 |
|